27 results
424B3
BIAF
BioAffinity Technologies Inc
16 Apr 24
Prospectus supplement
7:19pm
in the Bonus Plan will be entitled to receive payment of the award for a plan year only after certification by the Compensation Committee that the targets
POS AM
BIAF
BioAffinity Technologies Inc
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
certification by the Compensation Committee that the targets associated with such award have been satisfied. Final payments with respect to awards will vary … in broad-spectrum cancer treatments. bioAffinity Technologies develops proprietary noninvasive diagnostic tests using technology that preferentially targets
424B5
kox19xn2s63s3fmbplh
8 Mar 24
Prospectus supplement for primary offering
12:18pm
424B5
xp2i 4yu4
7 Mar 24
Prospectus supplement for primary offering
9:57pm
8-K
65qza6ff4tck
31 Jan 24
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
llhxx auu
31 Jan 24
Departure of Directors or Certain Officers
4:05pm
424B5
sv7wva4dq na1p4ms
28 Nov 23
Prospectus supplement for primary offering
4:00pm
S-3
i68z4fl0e85v7u qzclg
16 Nov 23
Shelf registration
5:23pm
DRS
2xys akqgkcy
14 Aug 23
Draft registration statement
12:00am
10-K
epi58rsf69p
31 Mar 23
Annual report
3:40pm
10-Q
biiro4lwm4m3e1 mur9
14 Nov 22
Quarterly report
5:11pm
8-K
EX-99.1
c2vn7ax8bee6jsr
6 Sep 22
Entry into a Material Definitive Agreement
1:15pm